HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 701Generated: October 28, 2026
1-Methylpiperazine → 1-(4-Chloro-2-methoxyphenyl)-4-methylpiperazine
https://huagongshe.com/reaction/701
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | 4-Chloro-1-iodo-2-methoxybenzene | HCID 16079230 | — |
| Reagent | Sodium t-butoxide | HCID 23676156 | — |
| Catalyst | Binap, (A+-)- | HCID 634876 | — |
| Catalyst | Palladium (II) acetate | HCID 4144353 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 1-(4-Chloro-2-methoxyphenyl)-4-methylpiperazine | HCID 119087195 | 0% |
Reaction Steps
1-methylpiperazine (0.021 mL, 0.19 mmol) was added to 4-chloro-1-iodo-2-methoxybenzene (50 mg, 0.19 mmol) and sodium 2-methylpropan-2-olate (35.8 mg, 0.37 mmol) in toluene (0.650 mL) and the solution degassed. rac-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (11.60 mg, 0.02 mmol) and Palladium II acetate (4.18 mg, 0.02 mmol) were added to the resulting mixture and the vial stirred at 80 °C for 17 hours. LCMS revelead product peak, but not great. Product not isolated.
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-a9eb8bf838c248b3ad5908714b48274f |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|